Francois Laporte

Dr. Francois Laporte

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Toxicology in Vitro
Verified
Journal Article
Closed access
PCPierre Champelovier
Pierre Champelovier
XCXavier Chauchet
Xavier Chauchet
FPFlorence PUCH
Florence PUCH
SVSabrina Vergnaud
Sabrina Vergnaud
CGCatherine Garrel
Catherine Garrel
Ahcène BoumendjelAhcène Boumendjel
Ahcène Boumendjel

1 September 2008 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
AGAnnabelle Guiraud
Annabelle Guiraud
MLMichel De Lorgeril
Michel De Lorgeril
SZSabrina Zeghichi
Sabrina Zeghichi
FLFrancois Laporte
Francois Laporte
PSPatricia Salen
Patricia Salen
JLJoël de Leiris
Joël de Leiris
Moderate ethanol drinking (ED) andn-3 fatty acids have both been associated with low cardiac mortality. However, there are few data evaluating the interactions of ED withn-3. We recently reported that moderate ED results in increasedn-3 in cardiac patients. The main aim of the present study was, through a well-controlled experimental model, to confirm that chronic ED actually results in increasedn-3. Secondary aims were to examine the effects of chronic ED on cardiac mitochondria, cardiac function and experimental myocardial infarction. We studied the fatty acid profiles of plasma, cell membranes and cardiac mitochondria phospholipids in a rat model of chronic ED. In plasma and cell membranes, ED actually resulted in highern-3 (P = 0·005). In mitochondria phospholipids of ED rats,n-3 were also increased (P < 0·05) but quite modestly. Cardiac mitochondrial function and left ventricular function were not significantly different in ED and control rats, while infarct size after 30 min ischaemia and reperfusion was smaller (P < 0·0001) in ED rats. This is the first animal study confirming interaction of alcohol drinking withn-3. We found no harmful effect of chronic ED on the heart in that model but a significant cardioprotection. Further studies are warranted to investigate the mechanisms by which moderate ED alters the metabolism ofn-3 and whethern-3 are the mediators of the ED-induced cardioprotection.

1 July 2014 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Open access
XFXavier Forceville
Xavier Forceville
STSamia Touati
Samia Touati
PTPhilippe Le Toumelin
Philippe Le Toumelin
VDVéronique Ducros
Véronique Ducros
FLFrancois Laporte
Francois Laporte
DADiane Agay
Diane Agay
Both septic shock and sodium selenite (Na2SeO3) lead to multiple organ failure through oxidation. Na2SeO3 has direct oxidant effects above the nutritional level and indirect anti-oxidant properties. In a lipopolysaccharide (LPS) rat model we assessed margin of safety, toxicity and beneficial effect of pentahydrate Na2SeO3 (5H2O·Na2SeO3) at oxidant doses. In a three-step study on 204 rats we: (i) observed toxic effects of Na2SeO3 injected intraperitoneously (IP) and determined its Minimum Dose Without Toxic effect (MDWT) 0.25-0.35 mg/kg selenium (Se) content; (ii) injected IP LPS at 70% lethal dose (LD) followed, or not, one hour later by IP Na2SeO3 at MDWT and (iii) by doses>MDWT. At 48 h, in survivors, we measured plasma creatinine, lactate, aspartate and alanine aminotransferase (AST, ALT), nitric oxide (NO) and Se concentrations. (i) Na2SeO3 alone did not increase NO and lactate. Encephalopathy appeared at 1mg Se/kg. Creatinine increased at 1-1.75 mg Se/kg, AST, ALT at 3-4.5 mg Se/kg, and the minimum LD was 3 mg Se/kg. (ii) Mortality after LPS was 37/50 (74%, [62-86%]) vs. 20/30 (67%, [50-84%]) when followed by Na2SeO3 at MDWT (p=0.483) with a decreased in NO (-31%, p=0.038) a trend for lactate decrease (-19%, p=0.068) and an increased Se in plasma of survivals. (iii) All rats died at doses ≥0.6 mg/kg (p<0.001). Mechanisms of LPS and Na2SeO3 toxicity differ (i.e. NO, lactate). In septic shock 5H2O·Na2SeO3 toxicity increased, margin of safety decrease, but IP administration of dose considered as oxidant of 5H2O·Na2SeO3 showed beneficial effects.

21 February 2017 in Clinical Nutrition Experimental
Verified
Journal Article
Open access
PDF file
Christine DemeilliersChristine Demeilliers
Christine Demeilliers
MTMarie-Claire Toufektsian
Marie-Claire Toufektsian
PSPatricia Salen
Patricia Salen
FLFrancois Laporte
Francois Laporte
KPKatia Petroni
Katia Petroni
MLMichel de Lorgeril
Michel de Lorgeril
Background This study aimed at exploring whether moderate ethanol drinking may have adverse effects on the fatty acids composition and on mitochondrial DNA (mtDNA) of rat brain. A secondary aim was to examine whether dietary antioxidant anthocyanins (ACN) can be protective. Methods One group of rats received ethanol 12% and another water as an exclusive liquid to drink for 8 weeks. In order to test the impact of ACN consumption, two other groups of rats were fed an ACN-rich diet in combination with either ethanol or water. Brain fatty acids were measured by gas chromatography and mtDNA alterations, markers of mitochondrial suffering, were studied through an original real-time qPCR-based protocol. Results Linoleic acid (LA, 18:2n-6) and eicosadienoic acid (20:2n-6) were significantly decreased, by 12% and 31% respectively, in the brains of both ethanol groups. The other brain lipids, including arachidonic acid (20:4n-6) and n-3 polyunsaturated fatty acids, were not modified. These changes were associated with a significant increase in deleted mtDNA (by 28%) in the ethanol group, without total mtDNA depletion. The ACN-rich diet prevented the increase in mtDNA common deletion (mtDNA CD). Conclusion These data demonstrate that moderate ethanol drinking reduces certain brain n-6 and results in mtDNA injury. The antioxidant anthocyanins protect brain mtDNA but do not restore normal n-6 levels. Further studies are required to investigate the consequences of a decrease in n-6 levels in brain.

21 December 2018 in Cancers
Verified
Journal Article
Open access
PDF file
SBSylvie Berthier
Sylvie Berthier
LLLouis Larrouquère
Louis Larrouquère
PCPierre Champelovier
Pierre Champelovier
ECEdwige Col
Edwige Col
CLChristine Lefebvre
Christine Lefebvre
FPFlorence PUCH
Florence PUCH
Glioblastoma multiform (GBM) tumors are very heterogeneous, organized in a hierarchical pattern, including cancer stem cells (CSC), and are responsible for development, maintenance, and cancer relapse. Therefore, it is relevant to establish new GBM cell lines with CSC characteristics to develop new treatments. A new human GBM cell line, named R2J, was established from the cerebro-spinal fluid (CSF) of a patient affected by GBM with leptomeningeal metastasis. R2J cells exhibits an abnormal karyotype and form self-renewable spheres in a serum-free medium. Original tumor, R2J, cultured in monolayer (2D) and in spheres showed a persistence expression of CD44, CD56 (except in monolayer), EGFR, Ki67, Nestin, and vimentin. The R2J cell line is tumorigenic and possesses CSC properties. We tested in vitro the anticancer effects of sodium selenite (SS) compared to temozolomide TMZ. SS was absorbed by R2J cells, was cytotoxic, induced an oxidative stress, and arrested cell growth in G2M before inducing both necrosis and apoptosis via caspase-3. SS also modified dimethyl-histone-3-lysine-9 (H3K9m2) levels and decreased histone deacetylase (HDAC) activity, suggesting anti-invasiveness potential. This study highlights the value of this new GBM cell line for preclinical modeling of clinically relevant, patient specific GBM and opens a therapeutic window to test SS to target resistant and recurrent GBM.